Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) was the target of a large drop in short interest in June. As of June 30th, there was short interest totaling 1,984 shares, a drop of 60.4% from the June 15th total of 5,004 shares. Based on an average daily trading volume, of 154,020 shares, the short-interest ratio is currently 0.0 days.
Tevogen Bio Stock Performance
Tevogen Bio stock opened at $0.06 on Monday. The company’s 50-day moving average price is $0.04 and its 200-day moving average price is $0.04. Tevogen Bio has a twelve month low of $0.03 and a twelve month high of $0.08.
About Tevogen Bio
Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.
The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.
Featured Stories
- Five stocks we like better than Tevogen Bio
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
